V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002014 | 230006576 | 1.59 | 58.7 | null | null | 2020-11-01 | null | 02 | null | TRIAL UNSPECIFIED | 100142846 |
| 230002018 | 230006577 | 1.64 | 61 | null | 2018-04-06 | 2019-06-08 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100227310 |
| 230002019 | 230006578 | 1.54 | 61 | null | 2022-01-14 | 2022-01-17 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100775843 |
| 230002021 | 230006579 | 1.74 | 63 | null | null | 2021-08-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100244440 |
| 230002023 | 230006581 | 1.66 | 81.3 | null | 2017-08-19 | 2017-12-16 | null | null | null | NIVOLUMAB | 101154209 |
| 230002024 | 230006582 | 1.53 | 71.2 | null | 2019-08-20 | 2019-09-04 | null | null | null | RUCAPARIB | 101534467 |
| 230002026 | 230006583 | 1.57 | 74.6 | null | 2020-08-24 | 2020-08-31 | Olaparib | 02 | null | OLAPARIB | 100342444 |
| 230002027 | 230006584 | null | 43.1 | null | 2019-09-25 | 2019-10-08 | null | null | null | NIRAPARIB | 101310432 |
| 230002031 | 230006585 | null | null | Adjuvant (A) | 2020-02-15 | 2020-02-25 | null | null | N | BEVACIZUMAB | 101678575 |
| 230002037 | 230006587 | 1.57 | 73.5 | Palliative (P) | 2019-06-16 | 2019-09-16 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100762527 |
| 230002040 | 230006588 | 1.69 | 89.5 | 03 | null | 2021-03-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | TRIAL UNSPECIFIED | 100993742 |
| 230002041 | 230006589 | 1.61 | 111 | null | 2018-07-14 | 2018-07-25 | Olaparib | 02 | null | OLAPARIB | 100942257 |
| 230002043 | 230006590 | 1.64 | 108.4 | null | 2019-07-16 | 2019-08-21 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101645607 |
| 230002045 | 230006591 | 1.52 | 104.9 | null | 2017-10-23 | 2017-12-04 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101121861 |
| 230002047 | 230006592 | 1.54 | 92.6 | null | 2020-11-14 | 2020-12-05 | GEMCITABINE | 02 | null | CYCLOPHOSPHAMIDE + ETOPOSIDE | 101483966 |
| 230002049 | 230006593 | null | null | null | 2019-06-01 | 2019-06-14 | PACLITAXEL | 02 | null | PACLITAXEL | 101426792 |
| 230002050 | 230006594 | 1.63 | 43.5 | null | 2019-07-13 | 2019-08-07 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101559296 |
| 230002051 | 230006595 | 1.61 | 77.5 | null | 2020-02-25 | 2020-02-25 | null | 02 | null | CARBOPLATIN + LIPOSOMAL DOX | 101668059 |
| 230002052 | 230006596 | 1.68 | 105.55 | null | null | 2018-08-16 | ICON8B TRIAL | 02 | null | NIVOLUMAB | 100523092 |
| 230002053 | 230006597 | null | null | Palliative (P) | 2019-08-29 | 2019-09-14 | PACLITAXEL | 02 | N | PACLITAXEL | 100269365 |
| 230002054 | 230006598 | 1.75 | 61.5 | null | 2019-08-27 | 2020-01-03 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100789824 |
| 230002057 | 230006599 | null | null | null | 2016-12-06 | 2016-12-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100730585 |
| 230002060 | 230006600 | 1.5 | 95 | null | null | 2019-04-18 | PACLITAXEL | 02 | N | PACLITAXEL | 100781723 |
| 230002061 | 230006601 | null | null | null | 2021-03-25 | 2021-03-26 | null | null | null | OLAPARIB | 100507338 |
| 230002063 | 230006602 | 1.62 | 54.3 | Palliative (P) | 2017-09-21 | 2017-09-25 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100886582 |
| 230002065 | 230006604 | 1.72 | 84 | null | null | 2017-02-18 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101004899 |
| 230002066 | 230006605 | null | null | Not known (9) | 2020-07-28 | 2020-07-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101067457 |
| 230002067 | 230006606 | 1.52 | 74 | null | null | 2017-11-18 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101408196 |
| 230002068 | 230006607 | 0 | 90 | null | 2022-01-28 | 2022-02-10 | null | null | null | PACLITAXEL | 101506674 |
| 230002069 | 230006608 | 1.67 | 74 | null | 2019-11-13 | 2019-11-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100804248 |
| 230002073 | 230006610 | 1.68 | 63.4 | Palliative (P) | 2017-03-15 | 2017-03-17 | null | null | N | LIPOSOMAL DOXORUBICIN | 100519661 |
| 230002075 | 230006612 | 1.53 | 48.4 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101208932 |
| 230002076 | 230006613 | null | null | Palliative (P) | null | 2017-03-13 | null | null | N | CARBOPLATIN | 101269238 |
| 230002077 | 230006614 | 1.67 | 66.8 | Palliative (P) | 2017-04-21 | 2017-05-05 | DICE TRIAL | 02 | N | CAPECITABINE | 101474197 |
| 230002078 | 230006615 | 1.54 | 63.5 | null | null | 2017-11-30 | null | 02 | null | ETOPOSIDE | 101221344 |
| 230002080 | 230006616 | 1.76 | 69.6 | Palliative (P) | 2022-03-27 | 2022-04-12 | Niraparib | 02 | N | NIRAPARIB | 101400778 |
| 230002083 | 230006618 | 1.71 | 77.2 | null | 2020-11-03 | 2021-05-03 | Carboplatin AUC 2 - 5 | 02 | null | TRIAL UNSPECIFIED | 101596463 |
| 230002084 | 230006619 | null | null | null | 2018-05-06 | 2018-05-24 | null | null | null | GEMCITABINE + TREOSULFAN | 100495181 |
| 230002085 | 230006620 | 1.49 | 67 | null | null | 2019-10-04 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100345867 |
| 230002086 | 230006621 | null | null | Adjuvant (A) | 2021-04-12 | 2021-04-17 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100580166 |
| 230002089 | 230006622 | 1.7 | 110.6 | null | 2020-02-11 | 2020-02-13 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101402009 |
| 230002090 | 230006623 | 1.59 | 119 | 03 | null | 2020-07-25 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101765445 |
| 230002092 | 230006625 | 1.61 | 59.8 | Adjuvant (A) | 2018-11-20 | 2020-11-01 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100758939 |
| 230002093 | 230006626 | null | null | null | 2016-08-21 | 2016-09-12 | null | null | null | PACLITAXEL | 101534372 |
| 230002095 | 230006628 | 1.47 | 91.8 | null | 2020-01-09 | 2020-01-20 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100288931 |
| 230002097 | 230006630 | null | null | null | 2018-05-14 | 2018-05-21 | null | 02 | null | TRIAL UNSPECIFIED | 100918154 |
| 230002098 | 230006631 | null | null | null | 2020-11-21 | 2020-11-24 | null | null | null | CYCLOPHOSPHAMIDE | 101686199 |
| 230002103 | 230006634 | 1.53 | 62 | Palliative (P) | 2015-05-25 | 2017-09-05 | null | 02 | N | AZACITIDINE | 100948984 |
| 230002105 | 230006636 | null | null | null | 2021-07-10 | 2021-07-17 | Rucaparib | 02 | null | RUCAPARIB | 100862708 |
| 230002108 | 230006637 | 1.74 | 87.05 | null | null | 2020-04-08 | PACLITAXEL | 02 | null | PACLITAXEL | 100441467 |